09:44 AM EST, 12/24/2024 (MT Newswires) -- Achilles Therapeutics ( ACHL ) shares were up 1.1% Tuesday morning after the company said it sold certain technology assets to AstraZeneca ( AZN ) for $12 million.

The company said it transferred a commercial license of proprietary data and samples from the TRACERx non-small cell lung cancer study to AstraZeneca ( AZN ).

Achilles said the sale concludes a strategic review it had first announced in September. The company said it now plans to further reduce its employee headcount and decrease the size of its board.

Price: 0.99, Change: +0.01, Percent Change: +1.11